Agios Pharmaceuticals Statistics

Total Valuation

LON:0HB0 has a market cap or net worth of GBP 1.41 billion. The enterprise value is 413.26 million.

Market Cap	1.41B
Enterprise Value	413.26M

Important Dates

The next estimated earnings date is Thursday, August 7, 2025.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	57.92M
Shares Outstanding	n/a
Shares Change (YoY)	+3.98%
Shares Change (QoQ)	+0.63%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	51.28M

Valuation Ratios

The trailing PE ratio is 2.74.

PE Ratio	2.74
Forward PE	n/a
PS Ratio	49.31
PB Ratio	1.25
P/TBV Ratio	1.25
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	0.80
EV / Sales	15.30
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-1.32

Financial Position

The company has a current ratio of 18.50, with a Debt / Equity ratio of 0.04.

Current Ratio	18.50
Quick Ratio	17.12
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	-0.13
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 60.26% and return on invested capital (ROIC) is -23.60%.

Return on Equity (ROE)	60.26%
Return on Assets (ROA)	-22.88%
Return on Invested Capital (ROIC)	-23.60%
Return on Capital Employed (ROCE)	-29.29%
Revenue Per Employee	58,860
Profits Per Employee	1.06M
Employee Count	488
Asset Turnover	0.03
Inventory Turnover	11.77

Taxes

In the past 12 months, LON:0HB0 has paid 34.24 million in taxes.

Income Tax	34.24M
Effective Tax Rate	6.23%

Stock Price Statistics

The stock price has decreased by -23.10% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-23.10%
50-Day Moving Average	30.37
200-Day Moving Average	38.44
Relative Strength Index (RSI)	56.06
Average Volume (20 Days)	99

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	7.04

Income Statement

In the last 12 months, LON:0HB0 had revenue of GBP 28.66 million and earned 515.47 million in profits. Earnings per share was 8.86.

Revenue	28.66M
Gross Profit	-211.30M
Operating Income	-340.78M
Pretax Income	549.71M
Net Income	515.47M
EBITDA	-336.46M
EBIT	-340.78M
Earnings Per Share (EPS)	8.86

Full Income Statement

Balance Sheet

The company has 691.46 million in cash and 40.98 million in debt, giving a net cash position of 1.06 billion.

Cash & Cash Equivalents	691.46M
Total Debt	40.98M
Net Cash	1.06B
Net Cash Per Share	n/a
Equity (Book Value)	1.14B
Book Value Per Share	19.61
Working Capital	709.17M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -310.73 million and capital expenditures -1.79 million, giving a free cash flow of -312.52 million.

Operating Cash Flow	-310.73M
Capital Expenditures	-1.79M
Free Cash Flow	-312.52M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-1,188.86%
Pretax Margin	1,917.72%
Profit Margin	1,798.26%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LON:0HB0 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.98%
Shareholder Yield	n/a
Earnings Yield	36.47%
FCF Yield	-22.11%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0HB0 has an Altman Z-Score of 15.14 and a Piotroski F-Score of 4.

Altman Z-Score	15.14
Piotroski F-Score	4